GlassScriptPhysician profile
Chloe E Callier
NPI 1376172767
$2,223.74
in general payments reported to CMS, 2019-2025
13 companies · $1,014 in 2025
The $1,014 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $88.73 · 2021: $130 · 2022: $572 · 2023: $171 · 2024: $248 · 2025: $1,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $433.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,000.00 | 2025 | |
| Davol INC. | $301.65 | 2022-2024 | Arista Ah Flexitip |
| Inari Medical, INC. | $233.22 | 2022 | |
| Baxter Healthcare | $187.71 | 2020-2022 | |
| Becton, Dickinson and Company | $147.46 | 2023 | Phasix Mesh |
| Abiomed | $115.62 | 2021 | |
| Ethicon US, LLC | $103.82 | 2021-2024 | Enseal X1 |
| Prytime Medical Devices, INC. | $51.11 | 2024 | Er-Reboa Plus |
| W. L. Gore & Associates, INC. | $32.09 | 2023-2024 | Gore Propaten Vascular Graft |
| Kci USA, INC. | $17.49 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.45 | 2025 | Entyvio |
| Allergan, INC. | $11.79 | 2022 | |
| Kerecis Limited | $7.33 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chloe Callier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.